BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
57.35
-0.87 (-1.49%)
At close: Apr 17, 2026

SHA:688166 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
961.06765.35998.051,180336.84
Trading Asset Securities
--50.6250.120.76
Cash & Short-Term Investments
961.06765.351,0491,230337.6
Cash Growth
25.57%-27.02%-14.78%264.48%-35.02%
Accounts Receivable
330.02339.5308.88307.47373.85
Other Receivables
9.136.6619.9118.783.75
Receivables
339.14346.17328.79326.25377.59
Inventory
364.25364.61344.63280.35200.06
Prepaid Expenses
--3.655.834.48
Other Current Assets
124.04164.1411495.3973.27
Total Current Assets
1,7891,6401,8401,938993.01
Property, Plant & Equipment
2,7522,7052,4892,0761,378
Long-Term Investments
671.08437.06425.86399.33348.28
Goodwill
-3.127.57.57.5
Other Intangible Assets
79.5389.4893.6681.6480.84
Long-Term Accounts Receivable
4.12.1---
Long-Term Deferred Tax Assets
94.6862.242.2823.9419.86
Long-Term Deferred Charges
339.1957.4930.1826.8725.83
Other Long-Term Assets
95.42156.03104.09107.73115.86
Total Assets
5,8255,1535,0324,6612,970
Accounts Payable
185.89266228.18252.19211.89
Accrued Expenses
82.9772.0172.3169.0461.72
Short-Term Debt
110.11115.26156.87124.38257.05
Current Portion of Long-Term Debt
775.1516.96397.93313.8716.58
Current Portion of Leases
8.8313.6916.11.349.87
Current Income Taxes Payable
10.6116.6814.0414.973.69
Current Unearned Revenue
25.5628.022429.4920.33
Other Current Liabilities
81.2323.7612.816.261.93
Total Current Liabilities
1,2801,052922.25811.52583.07
Long-Term Debt
1,4901,5801,6151,576618.69
Long-Term Leases
10.2110.2121.016.010.22
Long-Term Unearned Revenue
167.5884.7126.252626
Other Long-Term Liabilities
30.3-29.82--
Total Liabilities
2,9792,7272,6142,4201,228
Common Stock
423.1422.47422.47422.47410
Additional Paid-In Capital
1,076982.361,0571,008738.94
Retained Earnings
1,0661,046897.66743.35555.05
Treasury Stock
-20.05-10.01---
Comprehensive Income & Other
-24.21-57.82-8.6417.77-25.8
Total Common Equity
2,5212,3832,3692,1921,678
Minority Interest
325.0142.7348.9750.0463.45
Shareholders' Equity
2,8462,4262,4182,2421,742
Total Liabilities & Equity
5,8255,1535,0324,6612,970
Total Debt
2,3952,2362,2072,022902.42
Net Cash (Debt)
-1,433-1,470-1,158-791.15-564.82
Net Cash Per Share
-3.42-3.50-2.75-1.91-1.39
Filing Date Shares Outstanding
422.54422.11422.1422.47410
Total Common Shares Outstanding
422.54422.11422.47422.47410
Working Capital
508.2587.89917.491,127409.94
Book Value Per Share
5.975.655.615.194.09
Tangible Book Value
2,4422,2912,2672,1031,590
Tangible Book Value Per Share
5.785.435.374.983.88
Buildings
745.28728.65261.26273.4104.72
Machinery
1,2711,122704.8318.41287.37
Construction In Progress
1,1871,1671,7361,6661,131
Source: S&P Global Market Intelligence. Standard template. Financial Sources.